Doing full fetal anatomical surveys during follow-up exams of low-risk pregnancies can identify unanticipated fetal anomalies, particularly if the exams are intended to monitor fetal growth.
Doing full fetal anatomical surveys during follow-up exams of low-risk pregnancies can identify unanticipated fetal anomalies, particularly if the exams are intended to monitor fetal growth.
Dr. Eugene C. Toy and colleagues in the obstetrics and gynecology department at the Methodist Hospital in Houston published their research in the Sept. 26 issue of the Journal of Ultrasound in Medicine. They studied charts at a low-risk maternity clinic between July 1, 2005, and June 30, 2006, from women who had at least one ultrasound examination after 18 weeks' gestation with a complete and normal fetal anatomic assessment and at least one follow-up sonogram. Regardless of the reason for the follow-up exam, full fetal anatomic surveys were performed on each one.
A total of 4269 ultrasound examinations were performed in this time period, but only 437 (10.2%) were follow-up studies and 101 of these were excluded because the first exam showed a suspected fetal anomaly. Another 42 exams were excluded for other reasons. This left 294 women whose follow-up sonograms were studied.
Unanticipated fetal anomalies were found in 21 (7.1%) of these follow-up exams. The anomaly found most often was renal pyelectasis, and sonograms repeated to evaluate fetal growth yielded the most anomalies of any kind. Of the 122 women who had exams to evaluate fetal growth, 15 sonograms (12.3%) showed a fetal anomaly. Of the 172 exams conducted for other reasons, only six sonograms (3.5%) showed an unexpected anomaly.
"The point is not necessarily to do more follow-up sonograms," Toy said, "but rather to do full fetal anatomical surveys when follow-up sonograms are done."
To evaluate the severity of the problems, the researchers identified those mothers in the study who required neonatal interventions, defined in this study as surgical or medical therapy or follow-up with a subspecialty specifically for the suspected fetal anomaly. Of the six patients whose follow-up exams for reasons other than fetal growth evaluation showed anomalies, none had neonatal interventions. However, six of the 15 anomalies (40%) identified from fetal growth evaluations were addressed through neonatal intervention.
The researchers concluded that a complete fetal anatomic survey on follow-up sonograms may identify unanticipated fetal anomalies, especially when those exams are being performed to evaluate fetal growth.
"Our experience is that the fetal anatomical survey adds only 3.5 minutes - thus adding minimal extra cost and effort," Toy said.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Month, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.